A Preventable Disease Is on the Rise: Tuberculosis in Quebec
TB cases are rising across Quebec. Faiz Ahmad Khan explains what’s driving the trend and why access to care matters.
News
Respiratory Research News from the Meakins-Christie Laboratories and the RESP program of the RI-MUHC. View our latest funding results, faculty and trainee awards, and our research featured in the media.
A Hidden Clue to Lifelong Health: The Height-GaP
Study by Ben Smith introduces height-GaP, a simple measure linking early-life growth adversity to adult mortality risk, revealing how childhood conditions shape lifelong health.
3D-Printed Lung Tissue: Advancing Personalized Respiratory Care
Darcy Wagner is pioneering 3D-printed lung tissue to repair damaged airways, paving the way for personalized respiratory treatments
From RNA to Personalized ILD Treatment
Deborah Assayag’s team receive D2R funding to identify blood-based markers that could enable earlier diagnosis and more personalized treatment of ILD
Cannabis Vaping: Regulated Does Not Mean Safe
Carolyn Baglole discuss the SQDC’s decision to sell cannabis vape products and why “regulated” should not be confused with “safe”
β-glucan and Dietary Supplements
Maziar Divangahi discusses his research on β-glucan and lung inflammation with Radio-Canada
A New mRNA-Based Approach to Treat Primary Ciliary Dyskinesia
Larry Lands and Darcy Wagner and team are developing an mRNA therapy to correct genetic errors in primary ciliary dyskinesia, opening new paths for treatment
Decade of Discovery in Trained Immunity: A Landmark eLife Focus Issue
A major eLife Focus Issue highlights 10+ years of trained immunity research, featuring key contributions from Meakins scientists
New MI4 Microbiomes and Rheumatic Diseases Grant to Irah King
Irah King receives MI4 funding to explore how alterations in the gut microbiome may drive the development of fibromyalgia
Expanding TB Prevention Could Save Millions of Lives
Study by Jonathon Campbell shows that scaling up existing TB screening and preventive treatments will save lives and costs